Ticker: RYTM

Company Overview Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is a biopharmaceutical firm dedicated to developing remedies for rare neuroendocrine diseases, focusing primarily on obesity linked to genetic deficiencies. Their main asset, IMCIVREE® (setmelanotide), has gained approvals in several ma...